Literature DB >> 2660886

Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference.

M Mosskin1, K Ericson, T Hindmarsh, H von Holst, V P Collins, M Bergström, L Eriksson, P Johnström.   

Abstract

Ten patients with findings at computed tomography (CT) suggesting intracranial supratentorial glioma were investigated to compare the diagnostic efficacy of this technique with that of positron emission tomography (PET) using 11C-methionine and examinations with magnetic resonance (MR). The findings were related to histopathologic examination of serial stereotactic biopsies, which were guided by the appearance of the lesions on PET examination. To obtain corresponding slice orientation with the different examination techniques, an individually shaped helmet fixation was used. However, in 3 cases this fixation device could not be used for MR. Histopathologic diagnosis, obtained in all cases from multiple target stereotactic biopsies, included glioma in 9 patients and reactive gliosis in one case. A detailed comparison of the three imaging techniques and the findings at stereotactic biopsies was possible in 7 patients, while in 3 patients comparison with MR was less exact due to the patient's refusal to wear the helmet during this examination. MR was the most accurate method for outlining the total extent of a lesion, i.e. the tumor and the edema surrounding it. Four lesions had homogeneous signal characteristics and in 6 lesions two (or more) compartments could be distinguished with MR. In 5 cases the MR findings were in complete agreement with the histopathologic findings. However, a thorough correlation between signal characteristics and histology was not possible. Using PET the occurrence and the extent of tumor tissue was correctly predicted in 7 patients. The PET was normal in one case. Findings at CT were in agreement with the histopathologic diagnosis in 5 patients. MR was the most sensitive method for the detection of lesions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2660886

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  33 in total

1.  Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.

Authors:  Nobuyuki Kawai; Yukito Maeda; Nobuyuki Kudomi; Keisuke Miyake; Masaki Okada; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

2.  A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.

Authors:  Makoto Ideguchi; Takafumi Nishizaki; Norio Ikeda; Tomomi Okamura; Yasue Tanaka; Natsumi Fujii; Machiko Ohno; Taichi Shimabukuro; Tokuhiro Kimura; Eiji Ikeda; Kazuyoshi Suga
Journal:  J Neurooncol       Date:  2018-03-07       Impact factor: 4.130

Review 3.  The Role of Standard and Advanced Imaging for the Management of Brain Malignancies From a Radiation Oncology Standpoint.

Authors:  Robert H Press; Jim Zhong; Saumya S Gurbani; Brent D Weinberg; Bree R Eaton; Hyunsuk Shim; Hui-Kuo G Shu
Journal:  Neurosurgery       Date:  2019-08-01       Impact factor: 4.654

4.  Correlation of intra-operative ultrasound with histopathologic findings after tumour resection in supratentorial gliomas. A method to improve gross total tumour resection.

Authors:  M Woydt; A Krone; G Becker; K Schmidt; W Roggendorf; K Roosen
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  CT, MRI, and PET in a case of intractable epilepsy.

Authors:  L Metsähonkala; T Aärimaa; P Sonninen; H Mikola; U Ruotsalainen; J Bergman
Journal:  Childs Nerv Syst       Date:  1996-07       Impact factor: 1.475

6.  Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.

Authors:  Douglas B Einstein; Barry Wessels; Barbara Bangert; Pingfu Fu; A Dennis Nelson; Mark Cohen; Stephen Sagar; Jonathan Lewin; Andrew Sloan; Yiran Zheng; Jordonna Williams; Valdir Colussi; Robert Vinkler; Robert Maciunas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-22       Impact factor: 7.038

7.  Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.

Authors:  Gabriele Pöpperl; Claudia Götz; Walter Rachinger; Franz-Josef Gildehaus; Jörg-Christian Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

Review 8.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

9.  Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.

Authors:  Ruben Dammers; Joost W Schouten; Iain K Haitsma; Arnaud J P E Vincent; Johan M Kros; Clemens M F Dirven
Journal:  Acta Neurochir (Wien)       Date:  2010-08-01       Impact factor: 2.216

10.  Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas.

Authors:  Bronwyn Stall; Leor Zach; Holly Ning; John Ondos; Barbara Arora; Uma Shankavaram; Robert W Miller; Deborah Citrin; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2010-01-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.